The global stomach cancer treatment market is on track for substantial expansion, with a projected market size of USD 11.47 billion by 2030. According to a recent market analysis, the market stood at USD 4.3 billion in 2022 and is anticipated to grow at a robust CAGR of 13% from 2023 to 2030.
Key Players
The major key players are Novartis AG, Pfizer, Inc., Mylan N.V., F. Hoffmann...
The global stomach cancer treatment market is on track for substantial expansion, with a projected market size of USD 11.47 billion by 2030. According to a recent market analysis, the market stood at USD 4.3 billion in 2022 and is anticipated to grow at a robust CAGR (compound annual growth rate) of 13% from 2023-2030.
Key Players
The major key players are Novartis AG, Pfizer,...
The global stomach cancer treatment market is on track for substantial expansion, with a projected market size of USD 11.47 billion by 2030. According to a recent market analysis, the market stood at USD 4.3 billion in 2022 and is anticipated to grow at a robust CAGR (compound annual growth rate) of 13% from 2023-2030.
Key Players
The major key players are Novartis AG, Pfizer,...
The global Cancer Biomarkers Market, valued at USD 22 billion in 2023, is anticipated to experience significant growth, reaching an estimated USD 52.18 billion by 2031. This projection represents a robust compound annual growth rate (CAGR) of 11.4% over the forecast period from 2024 to 2031.
Key Players
The major key players are F. Hoffmann-La Roche Ltd. (Switzerland), Thermo...
